{"schema_version":"secwatch.filing_event.v1","accession":"0001437402-26-000003","form_type":"8-K","ticker":"ARDX","cik":"0001437402","company_name":"ARDELYX, INC.","filed_at":"2026-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.083392+00:00","generated_at":"2026-05-16T11:11:51.087800+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Ardelyx reports preliminary Q4 2025 IBSRELA sales ~$87M, XPHOZAH ~$28M; cash $265M","bullets":["Preliminary unaudited U.S. net product sales: IBSRELA ~$87M Q4, ~$274M FY 2025.","Preliminary unaudited U.S. net product sales: XPHOZAH ~$28M Q4, ~$104M FY 2025.","Cash, cash equivalents and short-term investments ~$265M as of Dec 31, 2025, unaudited.","All figures are preliminary and subject to adjustment upon final audited results."],"urls":{"canonical":"https://secwatch.observer/filing/0001437402-26-000003","json":"https://secwatch.observer/filing/0001437402-26-000003.json","markdown":"https://secwatch.observer/filing/0001437402-26-000003.md","text":"https://secwatch.observer/filing/0001437402-26-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1437402/000143740226000003/0001437402-26-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1437402/000143740226000003/ardx-20260108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:11:51.087800+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}